Original ArticleAnnals of Demmatology 2023;35(3):190-204.https://doi.ong/10.5021/ad.22.168周Check for updatesGuidelines for the Management of Patients with AlopeciaAreata in Korea:Part I Topical and Device-based TreatmentHyunsun Park,Jung Eun Kim',Jee Woong Choi,Do Young Kim,Yong Hyun Jang',Young Lee',Jiehyun Jeon,Hyun-Tae Shin',Min Sung Kim,Jung Won Shin,Sung Bin Cho'o,Bark-Lynn Lew",Gwang Seong Choi?Department of Dermatology,SMG-SNU Boramae Medical Center,Seoul,Korea;'Department of Dermatology,College of Medicine,TheCatholic University of Korea,Seoul,Korea;Department of Dermatology,Ajou University School of Medicine,Suwon,Korea;Departmentof Dermatology,Yonsei University College of Medicine,Seoul,Korea;*Department of Dermatology,School of Medicine,KyungpookNational University,Daegu,Korea;Department of Dermatology,School of Medicine,Chungnam National University,Daejeon,Korea;Department of Dermatology,Guro Hospital,Korea University College of Medicine,Seoul,Korea;'Department of Dermatology,InhaUniversity School of Medicine,Incheon,Korea;Department of Dermatology,School of Medicine,Chosun University,Gwangju,Korea;Department of Dermatology,Seoul National University Bundang Hospital,Bundang,Korea;Yonsei Seran Dermatology and Laser Clinic,Seoul,Korea;"Department of Dermatology,Kyung Hee University School of Medicne,Seoul,KoreaReceived September 13,2022Background:Alopecia areata(AA)is a chronic disease with an unpredictable disease courseRevised December 17,2022and severe psychological impact.Accepted January 24,2023Objective:To provide evidence-and consensus-based insights regarding the treatment ofpatients with AA in Korea.Methods:We searched for relevant studies on the topical and device-based treatment of AAin the literature from inception until May 2021.Evidence-based recommendations were alsoprepared.The evidence for each statement was graded and classified according to the strengthof the recommendations.Hair experts from the Korean Hair Research Society (KHRS)votedon the statements,and an agreement of 75%or greater was considered as consensus.Results:Currently,there remains a scarcity of topical treatments,which is supported byrobust evidence from a number of high-quality randomized controlled trials.Current evi-dence supports the efficacy of topical corticosteroids,corticosteroid intralesional injection,and contact immunotherapy in AA patients.Topical corticosteroids and contact immuno-therapy are recommended for pediatric AA.A consensus was achieved in 6 out of 14(42.8%),Corresponding Authorand I out of 5(20.0%)statements pertaining to topical and device-based treatments in AA,Bark-Lynn Lewrespectively.The expert consensus was from a single country,and the study may not coverDepartment of Dermatology,Kyung HeeUniversity Hospital at Gangdong,892all the treatments used.Dongnam-ro,Gangdong-gu,Seoul 05278,Conclusion:The present study provides up-to-date,evidence-based treatment guidelines forKoreaAA based on the consensus reached among experts afte
